Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA)
Coya Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Edwards Lifesciences (EW) and Coya Therapeutics, Inc. (COYA)
Buy Rating Affirmed for Coya Therapeutics Amid Promising Drug Development and Regulatory Milestones
BTIG Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)
Buy Rating on Coya Therapeutics: Boosted Cash Reserves and Promising Development in Drug Research
Buy Rating Endorsed for Coya Therapeutics: Promising Therapeutic Advancements and Strong IP Portfolio
Positive Outlook for Coya Therapeutics: Novel Alzheimer's Treatments and Strategic Growth Initiatives Drive Buy Rating
Coya Therapeutics, Inc. (COYA) Gets a Buy From Chardan Capital
EF Hutton Reiterates Buy on Coya Therapeutics, Maintains $28 Price Target
Coya Therapeutics Analyst Ratings
EF Hutton Reiterates Buy on Coya Therapeutics, Maintains $28 Price Target
Coya Therapeutics Analyst Ratings
Coya Therapeutics Analyst Ratings
Coya Therapeutics, Inc. (COYA) Gets a Buy From BTIG
The Latest Analyst Ratings for Coya Therapeutics
Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11
Coya Therapeutics, Inc. (COYA) Receives a Buy From Chardan Capital
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Guardant Health (GH) and Coya Therapeutics, Inc. (COYA)
Analysts Conflicted on These Healthcare Names: Coya Therapeutics, Inc. (COYA) and Harmony Biosciences Holdings (HRMY)
No Data